RxDoctor Payments Data

Samuel Hughes, MD

Family Medicine · Statesville, NCNPI 1851825285

Payments from drug & device makers

$1,355in general payments, 2019–2025

Across 75 payments — averaging $18.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$314
  • AstraZeneca$294
  • Amgen$195
  • Lilly USA, LLC$183
  • Pfizer$108
  • Exact Sciences$50
  • plus $211 from 9 others

What the payments were for

  • Food & beverage$1,355100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,355 in reported general payments places this provider in the 70th percentile of 3,444 family medicine providers in North Carolina.

See all family medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$90,654
Medicare patients
130
Services billed
2,830

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide39$58,583
MounjaroTirzepatide39$47,129
FarxigaDapagliflozin Propanediol36$45,148
Repatha SureclickEvolocumab28$30,361
JardianceEmpagliflozin24$26,892
TrulicityDulaglutide20$25,514
EliquisApixaban30$21,165
Trelegy ElliptaFluticasone/Umeclidin/Vilanter26$20,407
JanuviaSitagliptin Phosphate12$16,539
Atorvastatin Calcium308$3,099
Rosuvastatin Calcium198$1,816
Levothyroxine Sodium122$1,437
Hydroxyzine Hcl33$1,201
Famotidine53$1,070
Gabapentin54$990

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$183$72,64359 claims
Novo NordiskOzempic$314$58,58339 claims
AstraZenecaFarxiga$294$45,14836 claims
Boehringer IngelheimJardiance$32$26,89224 claims
PfizerEliquis$108$21,16530 claims
GSKTrelegy Ellipta$31$20,40726 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 3,444 family medicine providers in North Carolina.

Other family medicine in Statesville

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →